Beradinelli-Seip syndrome
Berardinelli-Seip Syndrome Berardinelli-Seip Syndrome, also known as Congenital Generalized Lipodystrophy (CGL), is a rare genetic disorder characterized by the near-total absence of adipose tissue, leading to a variety of metabolic complications. This condition is named after the physicians who first described it, Dr. Waldemar Berardinelli and Dr. Martin Seip.
Clinical Features[edit | edit source]
Individuals with Berardinelli-Seip Syndrome typically present with a distinct set of clinical features:
- Lack of Adipose Tissue: Patients have a near-total absence of body fat from birth, which is a hallmark of the condition.
- Muscular Appearance: Due to the lack of subcutaneous fat, individuals often have a muscular appearance.
- Insulin Resistance: A common complication is severe insulin resistance, which can lead to Diabetes Mellitus.
- Acanthosis Nigricans: This is a skin condition characterized by dark, velvety patches, often associated with insulin resistance.
- Hepatomegaly: Enlargement of the liver is frequently observed due to fat accumulation in the liver.
- Hypertriglyceridemia: Elevated levels of triglycerides in the blood are common.
Genetic Basis[edit | edit source]
Berardinelli-Seip Syndrome is primarily caused by mutations in the AGPAT2 or BSCL2 genes. These genes are crucial for the normal development and function of adipose tissue.
- AGPAT2 Gene: Mutations in this gene disrupt the normal synthesis of triglycerides, leading to the absence of adipose tissue.
- BSCL2 Gene: This gene is involved in lipid droplet formation and storage, and its mutation leads to similar phenotypic outcomes.
Diagnosis[edit | edit source]
Diagnosis of Berardinelli-Seip Syndrome is based on clinical evaluation, family history, and genetic testing. The absence of adipose tissue can be confirmed through imaging studies such as MRI or CT scans.
Management[edit | edit source]
There is no cure for Berardinelli-Seip Syndrome, and management focuses on treating symptoms and preventing complications:
- Dietary Management: A low-fat diet may help manage hypertriglyceridemia.
- Medications: Insulin sensitizers and lipid-lowering agents are often used.
- Regular Monitoring: Patients require regular monitoring for diabetes, liver function, and cardiovascular health.
Prognosis[edit | edit source]
The prognosis for individuals with Berardinelli-Seip Syndrome varies. Early diagnosis and management of metabolic complications can improve quality of life and reduce the risk of severe complications.
Research and Future Directions[edit | edit source]
Ongoing research aims to better understand the genetic and molecular mechanisms underlying Berardinelli-Seip Syndrome, with the hope of developing targeted therapies in the future.
See Also[edit | edit source]
External Links[edit | edit source]
- Genetic and Rare Diseases Information Center
- [Lipodystrophy United](https://www.lipodystrophyunited.org/)
NIH genetic and rare disease info[edit source]
Beradinelli-Seip syndrome is a rare disease.
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
